-

APO Investor Alert: APOLLO GLOBAL MANAGEMENT, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting CEO Accountability: Levi & Korsinsky

Important Information Regarding Section 20(a) Individual Liability Claims

APO INVESTOR ALERT

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP alerts investors in Apollo Global Management, Inc. (NYSE: APO) of a pending securities class action naming two senior figures as individual defendants. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Apollo Global shares fell approximately 5%, a loss of $5.99 per share, closing at $113.73 following corrective disclosures. The Court has set May 1, 2026 as the deadline to apply for lead plaintiff appointment.

The Named Individual Defendants

Marc Rowan, who has served as Apollo Global's Chief Executive Officer at all relevant times, and Leon Black, co-founder and former CEO and chairman who retained 7.0% of the Company's common stock as of April 25, 2025, are both named as individual defendants. The action contends that both directly participated in the Company's management, were privy to confidential proprietary information, and were involved in drafting, reviewing, or disseminating the allegedly false statements at issue.

Section 20(a) Control Person Framework

The complaint charges that the Individual Defendants are liable as "controlling persons" under Section 20(a) of the Securities Exchange Act of 1934. As alleged, both defendants:

- Exercised power and authority over the contents of SEC filings, press releases, and public statements disseminated during the Class Period (May 10, 2021 through February 21, 2026)

- Possessed actual knowledge that the Company's repeated assertion it "never did any business with Jeffrey Epstein" was false, given their own documented communications with Epstein on Apollo business matters

- Had the ability to control, and did control, the Company's decision to incorporate the Dechert Report findings by reference into quarterly and annual filings

- Participated in the unlawful conduct that allegedly inflated the market price of Apollo Global securities

Sarbanes-Oxley Certification Obligations

Defendant Rowan signed SOX certifications attached to each quarterly Form 10-Q and annual Form 10-K filed during the Class Period. These certifications, required under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, attested to the accuracy of financial reporting, the disclosure of any material changes to internal controls, and the disclosure of all fraud. The pleading asserts that these certifications were signed while Rowan knew or recklessly disregarded that the Company's public statements concerning its relationship with Epstein were materially false.

Submit your information to join the recovery or call (212) 363-7500.

"Corporate officers have a duty to ensure their companies' public statements are accurate and complete. When executives sign SOX certifications attesting to the truthfulness of filings that allegedly repeat known falsehoods about the Company's dealings with Jeffrey Epstein, the question of personal accountability becomes central to this litigation." -- Joseph E. Levi, Esq.

To be considered for lead plaintiff, investors must file by May 1, 2026.

Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NYSE:APO

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

MO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Altria Group (MO)

NEW YORK--(BUSINESS WIRE)--Altria Group (NYSE: MO) shareholders took losses in late July 2026 when the Company reported second-quarter earnings and revenue below consensus and cut its full-year outlook -- an outlook management had reaffirmed on April 30, 2026 at adjusted diluted EPS of $5.56 to $5.72. If you suffered a loss on your Altria Group investment, you are encouraged to click here to submit your Altria loss information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikor...

TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)

NEW YORK--(BUSINESS WIRE)--Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 billion, Teladoc Health (NYSE: TDOC) reduced that outlook to $2.36 billion to $2.45 billion, and shares fell nearly 30%. If you lost money holding Teladoc Health shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.On the February 25, 2026 fourth qua...

PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)

NEW YORK--(BUSINESS WIRE)--A 22% single-session drop hit Pharming Group (PHAR) shares today after the Company reported Q2 2026 revenue of $90.2 million -- a 3% year-over-year decline against analyst consensus of roughly $419 million for the full year. If you lost money on PHAR, click here to submit your losses for review. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.The miss came from the Company's legacy product. RUCONEST sales...
Back to Newsroom